Net revenue for the 2025 sales cycle to date increased by 11% to BRL 1,129 million, driven by a 17% rise in annual contract value (ACV) conversion and strong growth in complementary solutions (24% expansion).
Adjusted EBITDA for the 2025 cycle to date was BRL 420 million with a margin of 37.2%, up 5% from the previous cycle, supported by operational efficiency and a favorable sales mix.
Free cash flow generation was a key highlight, totaling BRL 144 million in the 2025 sales cycle, representing a 176% increase year-over-year; the last twelve months free cash flow to adjusted EBITDA conversion rate improved from 42.5% to 50.8%.
Adjusted net profit for Q1 2025 was BRL 26 million, a 49% increase year-over-year, while adjusted net profit for the 2025 sales cycle was BRL 140 million, down 4.4% from the prior year due to product mix and revenue timing.
Management expects stable margins for 2025, with similar levels to 2024 (slightly above 30%), and anticipates continued high double-digit growth in complementary products and a strong B2G pipeline, though no specific guidance was provided for B2G growth.